ZOANN DREYER to fms-Like Tyrosine Kinase 3
This is a "connection" page, showing publications ZOANN DREYER has written about fms-Like Tyrosine Kinase 3.
Connection Strength
0.144
-
FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children's Oncology Group trial AALL0631. Leukemia. 2021 05; 35(5):1279-1290.
Score: 0.128
-
Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group study. Blood. 2012 Feb 23; 119(8):1872-81.
Score: 0.017